JUN 20, 2018 7:00 AM EDT

Utilizing Same-Day Sepsis Pathogen ID for Faster Therapy, Enhanced Stewardship, Improved Outcomes

Sponsored by: T2 Biosystems, Inc.
Speaker

Abstract

DATE: June 20, 2018
TIME: 07:00AM PDT, 10:00AM EDT

Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes and cost. One of the major hurdles to effective sepsis management is the limitations of conventional diagnostics, which are blood-culture based and take 1 to 5 or more days to identify sepsis-causing pathogens. Blood culture also misses 35-50% of infections altogether on first blood draw and can be greatly affected by the presence of antimicrobials. These delays impact patient outcomes as one hour of delayed treatment increases mortality risk by nearly 8%.

To advance sepsis care, hospitals are turning to new technology that does not rely on blood culture. This year, six new peer reviewed studies have been published on T2Dx diagnostics, which provide blood culture independent sepsis pathogen ID results in 3 to 5 hours. Due to improved detection, these studies from the U.S. and EU demonstrate that clinicians can achieve faster targeted therapy, better outcomes, enhanced stewardship, and reduced cost of care. The T2Dx Instrument runs the first FDA-cleared tests to identify deadly sepsis-causing pathogens in whole blood: the T2Candida Panel and the now FDA-Cleared T2Bacteria Panel.

In this webinar you will:

  • Review the latest clinical data on the accuracy and impact of blood culture independent diagnostics
  • Demonstrate the potential for new diagnostics to improve outcomes for patients suspected of sepsis while improving stewardship
  • Understand opportunities and barriers to implementation of blood culture independent diagnostics into routine clinical care and sepsis management protocols

Show Resources
You May Also Like
FEB 24, 2022 10:00 AM PST
C.E. CREDITS
FEB 24, 2022 10:00 AM PST
Date: February 24, 2021 Time: 10:00am (PST), 1:00pm (EST) One of the largest global public health crises is the rise of antimicrobial-resistant infections. Globally, over 700,000 people die...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
AUG 24, 2022 7:00 AM PDT
AUG 24, 2022 7:00 AM PDT
Date: August 24, 2022 Time: 7:00am (PDT), 10:00pm (EDT), 4:00pm (CEST) Light field microscopy was first introduced in 2006, and allows users to capture the 4D light field within the microsco...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
OCT 05, 2022 9:00 AM PDT
C.E. CREDITS
OCT 05, 2022 9:00 AM PDT
Date: October 05, 2022 Time: 11:00am (PST), 2:00pm (EST), 8:00pm (CEST) Candida auris is a multi-drug resistant yeast that continues to be a global threat for infection and transmission in h...
JUN 28, 2022 7:00 AM PDT
JUN 28, 2022 7:00 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
JUN 20, 2018 7:00 AM EDT

Utilizing Same-Day Sepsis Pathogen ID for Faster Therapy, Enhanced Stewardship, Improved Outcomes

Sponsored by: T2 Biosystems, Inc.


Show Resources
Loading Comments...
Show Resources